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Background: The fat mass and obesity associated gene (FTO) is widely investigated in humans regarding its
important roles in obesity and type 2 diabetes. Studies in mammals demonstrate that FTO is also associated with
inflammation markers. However, the association of FTO with inflammation in chickens remains unclear. In this study,
male chickens on day 28 posthatching were injected intraperitoneally with lipopolysaccharide (LPS) or saline to
investigate whether the FTO gene is involved in LPS-induced inflammation.
Results: We detected significant down-regulation of FTO mRNA in the liver (P < 0.01), but not in the hypothalamus,
2 and 24 h after LPS challenge. Toll-like receptor (TLR) 2 (P < 0.01) and TLR4 (P < 0.01) followed the same pattern as
FTO, being suppressed significantly in liver but not in hypothalamus. IL-1β was dramatically up-regulated (P < 0.01)
in both liver and hypothalamus 2 h after LPS challenge, while activation of IL-6 was observed in the liver (P < 0.01),
but not in hypothalamus. The 5′-flanking sequence of the chicken FTO gene contains nine predicted binding sites
for CCAAT/enhancer binding protein beta (C/EBP beta) and one for signal transducer and activator of transcription
3 (STAT3). Significant elevation of C/EBP beta was detected in the liver (P < 0.01), but not in the hypothalamus, 2 h after
LPS challenge. Lipopolysaccharide challenge increased the C/EBP beta binding to FTO promoter in the liver (P < 0.01
for fragment 1, P < 0.05 for fragment 2), although the protein content of C/EBP beta was not altered. Moreover, injec-
tion of LPS resulted in enhanced phosphorylation of liver STAT3, a downstream transcription factor in IL-6 signaling.
Although phosphorylated STAT3 was not detected to directly bind to FTO promoter, it was found to interact with C/
EBP beta.
Conclusion: Our results reveal that FTO expression in liver, but not in hypothalamus, is affected by the i.p. injection of
LPS, which may be mediated through tissue-specific FTO transcriptional regulation by C/EBP beta and STAT3 interaction.
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Fat mass and obesity associated gene (FTO) is strongly
associated with body mass index and obesity in human
genome wide association studies [1]. The role of FTO in
obesity has been further confirmed by transgenic ma-
nipulation in mice. FTO-deficient mice show reduced fat
mass in white adipose tissue [2], while ubiquitous over-
expression of FTO leads to increased food intake and fat
mass deposition [3]. Obesity is known to be related to
chronic subclinical inflammation which plays an import-
ant role in the development of type 2 diabetes and car-
diovascular diseases. FTO has been implicated to be
associated with inflammation [4]. Polymorphism of FTO
gene contributes to the variation in plasma level of C-
reactive protein, a marker of obesity-associated inflam-
mation [5]. Genetically modified mice with decreased
FTO activity exhibit improved inflammatory profile in
abdominal white adipose tissue [6].
FTO is ubiquitously expressed in multiple tissues, with
high abundance in liver and brain, especially hypothal-
amus. The liver and hypothalamus are both indispens-
able in the regulation of energy balance [7]. Hepatic and
hypothalamic FTO expression can be affected by feeding
status. In mice, FTO mRNA expression was significantly
reduced in hypothalamic arcuate nucleus [7], yet in-
creased in the liver [8], in response to fasting. In rats,
food deprivation [9] and high fat diet [10] remarkably in-
crease hypothalamic FTO mRNA expression. High fat
diet has been found to induce hypothalamic [11] and
hepatic [12] inflammation. To date, the association be-
tween FTO and obesity has been widely studied, whereas
how FTO expression in the liver and hypothalamus is
related to inflammation remains elusive.
Lipopolysaccharide (LPS) administration has been used
as a good model for studying systemic inflammation [13].
LPS-induced inflammatory response is mediated through
Toll-like receptor (TLR) 4, resulting in the expression of
proinflammatory cytokines, such as IL-1β and IL-6. FTO
was found to be expressed in leukocytes and was drastic-
ally upregulated in mouse macrophages in response to
the stimulation of interferon gamma and LPS [14]. Never-
theless, the mechanism underlying the inflammatory
stimulants-induced FTO expression is still unknown. Nu-
merous transcriptional factors are involved in the process
of inflammation, among which are signal transducer and
activator of transcription 3 (STAT3) and CCAAT/enhan-
cer binding protein beta (C/EBPβ) [15]. STAT3 signaling
pathway is reported to mediate the hypothalamic FTO
downregulation during energy restriction in rats [16],
whereas FTO may act as a coactivator of C/EBPβ, a
master transcriptional regulator of adipogenesis [17].
The expression and function of FTO in chickens re-
ceived much less attention compared to that in mammals.
It has been shown that the profile of FTO expression inchickens is similar to that in mammals [18]. FTO expres-
sion was decreased in ventral medial hypothalamus [18],
while increased in the liver [19], in response to fasting in
the chicken. Broiler chickens reared under commercial
condition are threatened by the large amounts of LPS
from the dust, and the inhalation of LPS causes the
chronic or acute inflammation. In order to elucidate the
possible involvement of FTO in the inflammation process,
here we use LPS injection as a pro-inflammatory stimulus
to examine the alterations of FTO expression in chicken
liver and hypothalamus. As the 5′ sequence of chicken
FTO gene contains predicted binding sites for both C/
EBPβ and phosphorylated STAT3 (p-STAT3), we further
investigated the role of these two transcription factors in
the regulation of FTO gene expression in response of LPS
challenge in the chicken.
Methods
Animals and experimental design
Fertile eggs laid by the Yellow Feathered Chicken were
obtained from Southern Poultry Breeding Company of
WENS Co. Ltd., Guangdong, China. Eggs were incu-
bated in an electric forced-draft incubator at 37.5 ± 0.5°C
and 60% relative humidity. On day 28 posthatching,
male chickens were selected and randomly divided into
control (saline) and LPS groups. Chickens in LPS group
were injected intraperitoneally with LPS from Escheri-
chia coli 055:B5 (L2880, Sigma-Aldrich) at a dose of
0.5 mg/kg body weight (BW). Chickens in the control
group were injected with the same volume of saline.
Two and 24 h after injection, liver and hypothalamus
were obtained and frozen in liquid nitrogen and stored
at −70°C. The hypothalamus was taken according to the
generally accepted standards. Briefly, the hypothalamus
was dissected from the ventral surface of the brain. Two
transverse cuts were made at the apex of the optic chi-
asm and the rostral margin of the mammillary bodies.
Bilateral cuts were then made 2 mm either side of the
midline and the whole hypothalamus was removed ac-
cording to the chicken brain atlas [20].
All experimental procedures were approved by the Ani-
mal Ethics Committee of Nanjing Agricultural University.
Quantitation of mRNA by real-time PCR
Frozen liver and hypothalamus samples were ground in
liquid nitrogen before total RNA extraction with TRIzol
reagent (15596026, Invitrogen). Total RNA extracts were
then treated with DNase I (D2215, Takara) to eliminate
possible contamination of genomic DNA. Two micro-
grams of total RNA were reverse transcribed and 2 μL of
diluted cDNA (1:20) were used for real-time PCR ana-
lysis. All the primers were listed in Table 1, and chicken
β-actin was selected as a reference gene. The method of
2-ΔΔCt was used to analyze the real-time PCR data. The
Table 1 Primer sequences used in real-time PCR analysis and ChIP assay
Target gene Sequence (F: forward, R: reverse) GenBank access Applications
IL-1β F: 5′-AACATCGCCACCTACAAG-3′ Y15006 mRNA quantification
R: 5′-TACTCGGTACATACGAGATGGAAA-3′
IL-6 F: 5′- CATGGACTGGAGCACAAGTA-3′ AJ309541.1 mRNA quantification
R: 5′-TGGAGAGCAGCCCATGTAA-3′
FTO F: 5′-TGAAGGTAGCGTGGGACATAGA-3′ NM_001185147 mRNA quantification
R: 5′-GGTGAAAAGCCAGCCAGAAC-3′
TLR2 F:5′-ATCCTGCTGGAGCCCATTCAGAG-3′ NM_ 204278.1 mRNA quantification
R:5′-TTGCTCTTCATCAGGAGGCCACTC -3′
TLR4 F: 5′-GTTTGACATTGCTCGGTCCT-3′ NM_001030693 mRNA quantification
R: 5′-GCTGCCTCCAGAAGATATGC-3′
C/EBPβ F: 5′- 5′-ACGAGGCGGACTGTTTGG-3′ NM_205253 mRNA quantification
R: 5′- GCTGCTGGGATGCTGCTAA-3′
STAT3 F: 5′- CAACAACCCCAAGAAC-3′ NM_001030931.1 mRNA quantification
R: 5′- GCTGAGACCACGCTTT-3′
β-Actin F: 5′-TGCGTGACATCAAGGAGAAG-3′ NM_205518 mRNA quantification
R: 5′-TGCCAGGGTACATTGTGGTA-3′
Fragment 1 F: 5′- AGTTTGCCTCATGCTGGTA-3′ ENSGALG00000003591 ChIP
R: 5′- CTGTAGCGAAGTTGGGTGG-3′
Fragment 2 F: 5′- CCAGGAGTTCCAGCATTA-3′ ENSGALG00000003591 ChIP
R: 5′- ATGGCTCCATCCAGTTGC-3′
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relative to the average level of the control group 2 h
after LPS challenge.
Western blot analysis
Protein extracts from frozen liver and hypothalamus sam-
ples were prepared as previously described [21]. Protein
concentrations were determined with a Pierce BCA
Protein Assay kit (23225, Thermo). Thirty micrograms of
protein extracts were subjected to electrophoresis on a
10% SDS-PAGE gel, and the separated proteins were
transferred onto nitrocellulose membranes (BioTrace, Pall
Co., USA). Immunoblotting was performed according to
the instructions of the manufacturer for each primary
antibody. Anti-C/EBPβ antibody (sc-150, 1:500) was pur-
chased from Santa Cruz Biotechnology; anti-pSTAT3
(9145, 1:2000) and anti-STAT3 antibody (4904, 1:2000)
were purchased from Cell Signaling Technology; anti-
GAPDH antibody (AP0066, 1:10,000) was purchased from
Bioworlde. Finally, the signals were detected by enhanced
chemiluminescence (ECL) using the LumiGlo substrate
(Super Signal West Pico Trial Kit, Pierce, USA). ECL sig-
nals were recorded by an imaging system (Bio-Rad, USA)
and analyzed with Quantity One software (Bio-Rad, USA).
The content of detected proteins was presented as the fold
change relative to the average content of the control
group 2 h after LPS challenge.Prediction of transcription factor binding sites and
Chromatin immunoprecipitation (ChIP) assay
The potential transcription factor binding sites were pre-
dicted on the 5′-flanking sequence of the chicken FTO
gene, about 3000 bp upstream of the translation start
site, by using TRANSFAC database. Nine potential bind-
ing sites for C/EBPβ and one for STAT3 were predicted
and the binding of these two factors on chicken FTO
promoter was verified with ChIP analysis.
ChIP analysis was performed according to our previ-
ous publication [22]. Briefly, 200 mg frozen liver samples
were ground in liquid nitrogen and washed with PBS
containing protease inhibitor cocktail (No. 11697498001,
Roche). After crosslinking with 1% formaldehyde, sam-
ples were lysed, and chromatin was harvested and soni-
cated to achieve 300–500 bp fragments. The crude
chromatin preparations were pre-cleared with 40 μL
protein A/G agarose beads (sc-2003, Santa Cruz Bio-
technology), and then incubated with 4 μg of anti-C/
EBPβ antibody overnight at 4°C. A negative control was
included with normal rabbit IgG (sc-2763, Santa Cruz
Biotechnology). Immuno-complexes were captured with
the beads and DNA fragments were released by reverse
cross-linking at 65°C for 8 h. Purified ChIP DNA was
used to amplify the FTO gene promoter sequences by
real-time PCR with specific primers (Table 1). ChIP re-
sults were calculated relative to the input and presented
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control group at 2 h.
Co-Immunoprecipitation
Two-hundred μg of protein extracts from frozen liver were
pre-cleared with 40 μL of protein A/G agarose beads at
4°C for an hour, and then immunoprecipitated with 4 μg of
antibodies to C/EBPβ overnight at 4°C. A negative control
was included with normal rabbit IgG. The protein com-
plexes were then captured by adding 40 μL of protein A/G
agarose beads. Immunoprecipitates were collected and de-
natured with electrophoresis sample buffer. The samples
were finally subjected to the Western bolt analysis.
Statistical analysis
All statistical analyses were performed with SPSS 17.0
for Windows. All data were expressed as mean ± SEM.
For body weight, liver weight, relative quantitative data
of gene/protein expression, one-way ANOVA was used
to access the effects. For ChIP assay results, a t test for
independent samples was applied. The level of signifi-
cance was set at P < 0.05 in all the analyses.
Results
LPS did not affect body weight, but increased relative
liver weight
Symptoms of somnolence, anorexia, adipsia, and ruffling
of the feathers were observed in chickens subjected to
LPS injection. However, no incidence of death was re-
corded during the experiment period. LPS injection did
not affect the body weight of chickens either 2 h or 24 h
after the LPS injection. However, the liver weight relative
to body weight increased significantly 2 h (P < 0.05) and
24 h (P < 0.01) after LPS injection (Table 2).
LPS down-regulated mRNA expression of FTO, TLR-4 and
TLR-2 in the liver but not hypothalamus
A tissue-specific response to LPS challenge was observed
for FTO, TLR-4 and TLR-2 mRNA levels (Figure 1).
Hepatic expression of FTO (Figure 1A), TLR-4 (Figure 1B)
and TLR-2 (Figure 1C) was significantly decreased (P <
0.05) 2 h and 24 h after LPS injection. In contrast,
hypothalamic expression of FTO (Figure 1D), TLR-4
(Figure 1E) and TLR-2 (Figure 1F) was not affected by
LPS injection.Table 2 Body weight, liver weight and liver index 2 h and 24
Parameters 2 h
Saline LP
Body weight (g) 277.98 ± 4.04 273.91
Liver weight (g) 8.61 ± 0.19 9.09 ±
Liver index (%) 3.10 ± 0.07 3.31 ±
Values are mean ± SEM. *P < 0.05 vs. Saline 2 h; **P < 0.01 vs. Saline 2 h.LPS induced expression of both IL-1β and IL-6 in liver,
but only IL-1β in hypothalamus
The mRNA expression of the pro-inflammatory cyto-
kines, IL-1β and IL-6, was determined in liver and hypo-
thalamus to assess the immune responses in respective
tissue following LPS challenge (Figure 2). In the liver,
both IL-1β (Figure 2A) and IL-6 (Figure 2B) were signifi-
cantly up-regulated (P < 0.01) 2 h after LPS injection, and
restored to the basal level 24 h. In hypothalamus, however,
only IL-1β (Figure 2C), but not IL-6 (Figure 2D), was acti-
vated (P < 0.01) 2 h and returned to the control level 24 h
after LPS injection.
LPS up-regulated C/EBPβ mRNA expression in the liver
but not hypothalamus
Hepatic expression of C/EBPβ mRNA was increased sig-
nificantly 2 h (P < 0.01) after LPS injection, and returned
to the control level at 24 h (Figure 3A). However, the
protein content of C/EBPβ in the liver was not affected
by LPS (Figure 3B). In contrast, hypothalamic expression
of C/EBPβ mRNA (Figure 3C) and protein (Figure 3D)
was not affected by LPS injection.
LPS induced STAT3 expression and activation in the liver
but not hypothalamus
In the liver, STAT3 mRNA abundance tended to be
higher (P =0.056) in LPS-treated chickens 2 h after LPS
injection (Figure 4A). The total STAT3 protein content
was decreased (P < 0.01) 2 h after LPS injection but re-
stored to the control level at 24 h. On the contrary,
phosphorylated STAT3 was significantly increased (P <
0.01) 2 h after LPS injection. As a result, the ratio of
phosphorylated STAT3 (p-STAT3) relative to total
STAT3 protein was higher in the liver of LPS-treated
chickens (Figure 4B). However, the activation of STAT3
was not detected in hypothalamus, as neither mRNA
abundance (Figure 4C) nor protein content (Figure 4D)
was affected by LPS injection.
LPS enhanced C/EBPβ binding to the 5′-flanking region of
chicken FTO gene
A schematic structure of chicken FTO gene promoter is
shown in Figure 5A. Nine C/EBPβ binding sites and one
STAT3 binding site were predicted. ChIP assay revealed
that C/EBPβ binding to the two FTO gene promoterh after LPS challenge
24 h
S Saline LPS
± 5.13 288.72 ± 7.43 283.70 ± 8.91
0.24 8.91 ± 0.25 10.97 ± 0.65**
0.05* 3.09 ± 0.06 3.86 ± 0.17**
Figure 1 mRNA expression of FTO (A, D), TLR4 (B, E) and TLR2 (C, F) in liver and hypothalamus after LPS injection. Values are mean ±
SEM, n = 6/group, □ means control group and ■ is LPS group. Values without common letters are different between two groups, P < 0.05.
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cantly enriched (P < 0.01 for fragment 1, P < 0.05 for
fragment 2) in the liver of LPS-treated chickens at 2 h
(Figure 5B). However, no specific binding of STAT3 to
chicken FTO promoter was detected, as the binding of
p-STAT3 did not differ from that of normal IgG, a
negative control (data not shown). Nevertheless, co-
immunoprecipitation analysis demonstrated the inter-
action of p-STAT3 and C/EBPβ in chicken liver.
Discussion
In this study, we successfully induced systemic inflam-
mation in the chicken by i.p. injection of LPS, which was
reflected by the sickness symptoms and remarkably in-
duced expression of inflammatory cytokines in the liver
and hypothalamus. IL-1β and IL-6 are regarded as the
key pro-inflammation cytokines triggering the acute
phase reaction in the liver and modifying the brain-
controlled functions such as fever and anorexia. It is re-
ported that LPS-induced expression of pro-inflammatorycytokines such as IL-1β and IL-6 is mediated by TLR4,
the recognition receptor of LPS [23]. However, the re-
sponses of pro-inflammatory mediators to LPS appear to
be different between liver and hypothalamus. Liver is
directly exposed to LPS and the Kupffer cells initiate the
inflammatory responses by releasing pro-inflammatory
cytokines such as IL-1β and IL-6, which communicate
with the hepatocytes to induce the acute phase re-
sponses [24]. However, hypothalamus is protected by the
blood–brain barrier (BBB) from the direct exposure to
the cytokines or LPS in the peripheral circulation. Yet,
the inflammatory mediators in the circulation can act
on the circumventricular organs (CVOs) that lack an ef-
fective BBB but contain cells equipped with the TLR4
and receptors for IL-1β and IL-6. The activated immune
responses in the CVOs further trigger the inflammation
in the other part of brain such as hypothalamus [25].
In this study, we detected the up-regulation of both IL-
1β and IL-6 in the liver, but only IL-1β in hypothal-
amus, in response to LPS injection in the chicken. This
Figure 2 mRNA expression of IL-1β (A, C) and IL6 (B, D) in liver and hypothalamus after LPS injection. Values are mean ± SEM, n = 6/
group, □ means control group and ■ is LPS group. Values without common letters are different between two groups, P < 0.05.
Figure 3 The expression of mRNA (A, C) and protein (B, D) of C/EBPβ in liver and hypothalamus after LPS treatment. Values are mean ±
SEM, n = 6/group, □ means control group and ■ is LPS group. Values without common letters are different between two groups, P < 0.05.
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Figure 4 mRNA expression of STAT3 in liver and hypothalamus (A, C), p-STAT3/t-STAT3 ratio in liver and hypothalamus (B, D) after LPS
injection. Values are mean ± SEM, n = 6/group, □ means control group and ■ is LPS group. Values without common letters are different between
two groups, P < 0.05.
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thalamus may be explained by the above-mentioned
differences in signal replay pathways mediating the
LPS-induced inflammation in liver and hypothalamus.
However, some studies in rodents reported the induction
of both IL-1β and IL-6 in hypothalamus following intra-
peritoneal injection of LPS [26-29]. This discrepancy may
attribute to the differences in species, as well as the dose
of LPS applied, and/or the timing of the sampling.
Nevertheless, the most interesting finding in this study
is the tissue-specific alteration in FTO expression in re-
sponse to LPS injection. To date, few evidences are
available linking FTO with inflammation. For instance,
FTO expression in subcutaneous adipose tissue is
negatively correlated with the IL-6 gene expression in
subcutaneous adipose tissue in morbidly obese German
women [30]. However, a cohort study on healthy
middle-aged Danish men failed to show the fatness-
independent effects of FTO rs9939609 A-allele, a genetic
variant most strongly associated with common obesity,
on a series of inflammatory markers. Nevertheless, FTO
A-allele tended to lower circulating IL-6 level [31]. In
the present study, we found negative correlation be-
tween FTO and IL-6 expression in chicken liver. LPS-induced hepatic up-regulation of IL-6 gene was found to
be associated with a remarkable reduction in FTO ex-
pression. Concurrently, FTO expression was not altered
in hypothalamus, where IL-6 expression was unaffected.
This finding suggests a role of IL-6, but not IL-1β, in the
regulation of FTO expression.
Although both IL-1β and IL-6 trigger the acute re-
sponses, they activate different protein kinase cascades
to accomplish the functions. IL-1β acts predominantly
through NF-κB-dependant pathway [32], whereas the
role of IL-6 is mainly mediated by Jak/STAT3 pathway
[33]. In our study, LPS challenge activated STAT3 sig-
naling in the liver, which was indicated by enhanced
STAT3 phosphorylation, despite a decrease in total
STAT3. In contrast, similar STAT3 activation was not
observed in the hypothalamus, which was in accordance
with the lack of IL-6 responses in this brain area. ChIP
analysis was employed to detect the direct binding of
pSTAT3 to chicken FTO promoter. To our disappoint-
ment, however, no direct binding of pSTAT3 to chicken
FTO promoter was found. It may not be surprising be-
cause only one putative STAT3 binding site was pre-
dicted on the 5′-flanking sequence of the chicken FTO
gene, about 3000 bp upstream of the translation start
Figure 5 Schematic structure of chicken FTO gene promoter
(A), C/EBPβ binding to FTO gene promoter 2 h after LPS injection
(B) and protein-protein interaction of p-STAT3 and C/EBPβ in liver
(C). Values are mean ± SEM, n = 6/group, □ means control group
and ■ is LPS group. *P < 0.05 vs Saline 2 h; **P < 0.01 vs Saline 2 h.
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FTO down-regulation in the hypothalamus of rats [16],
yet whether STAT3 directly binds to the promoter of
FTO remains unexplored. Recently, there are evidences
suggesting that STAT3 may participate in the regulation
of FTO expression through interacting with other tran-
scriptional factors, such as Cut-like Homeobox 1 (CUX1)
[34] which was proven to directly bind to the promoter of
FTO gene [35].
Some in vitro studies demonstrated that STAT3 inter-
acts with C/EBPβ [36] to transactivate the promoter of
Jun activation-domain binding protein 1 gene [37]. We
predicted 9 putative C/EBPβ binding sites on chicken
FTO gene promoter; therefore it is reasonable to specu-
late that STAT3 may regulate FTO expression via
protein-protein interaction with C/EBPβ in the process
of LPS- induced inflammation. Indeed, hepatic expression
of C/EBPβ was significantly up-regulated in response to
LPS injection, which is associated with evidently enhanced
binding of C/EBPβ to the promoter of chicken FTO gene.
Co-immunoprecipitation analysis further confirmed the
physical interaction of pSTAT3 and C/EBPβ in chicken
liver. However, the contribution of pSTAT3 and C/EBPβ
interaction to LPS-induced hepatic FTO repression re-
mains to be verified in the chicken.Although we provide here the evidence of LPS-
induced FTO repression in the liver of chickens, the
functional significance for such response is still un-
known. Due to the lack of specific antibody against
chicken FTO, we were not able to detect changes in
FTO protein content. The LPS-induced FTO gene regu-
lation may contribute to the adaptation of energy metab-
olism in the liver. Additionally, FTO was also reported
to be involved in STAT3 or C/EBPβ-mediated inflamma-
tory pathways. Overexpression of FTO remarkably in-
creased STAT3 expression in the arcuate nucleus of the
hypothalamus in rats [10] and in the chick embryonic
fibroblast cells [38]. Also, FTO was found to act as a
transcriptional coactivator to enhance the binding of C/
EBPβ to the promoter of target genes [17]. Moreover,
FTO has been characterized as a demethylase of N6-
methyl-adenosine (m6A) which was found widely distrib-
uted in the mammalian genes. And genes with this
modulation were found to involve in a variety of func-
tional categories including RNA metabolic process and
immune system related processes [39]. Whether the re-
sponse of hepatic FTO to the injection of LPS in chicken
was related to the function of being a demethylase is still
obscure. The functional relevance of LPS-induced FTO
repression in chicken liver as found in the present study
remains to be elucidated.
Conclusion
In summary, the present study demonstrated that FTO
gene expression in the chicken liver, but not hypothal-
amus, was down-regulated by the LPS challenge. IL-6
may act as a mediator regulating the LPS-induced hep-
atic FTO repression, through the mediation of C/EBPβ
and STAT3 interaction. Our findings may help to under-
stand the role of FTO in the LPS-induced inflammatory
responses in the chicken.
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